Pulmonary vascular and cardiac impairment in interstitial lung disease
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of...
Main Authors: | Marios Panagiotou, Alistair C. Church, Martin K. Johnson, Andrew J. Peacock |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2017-01-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/26/143/160053.full |
Similar Items
-
Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
by: Matthew Chin, et al.
Published: (2018-06-01) -
Pulmonary hypertension and pulmonary vascular disease: course report
by: Andrew Peacock, et al.
Published: (2018-03-01) -
Pulmonary hypertension in chronic interstitial lung diseases
by: Antonella Caminati, et al.
Published: (2013-09-01) -
Value of pulmonary rehabilitation in interstitial lung diseases
by: Anwar Ahmed Elganady, et al.
Published: (2020-01-01) -
Pulmonary function testing in children's interstitial lung disease
by: Astrid Madsen Ring, et al.
Published: (2020-07-01)